Helicobacter pylori eradication therapy in obese patients undergoing gastric bypass surgery-fourteen days superior to seven days?

Obesity Surgery

Volumn 21, Issue 9, 2011, Pages 1377-1381

  Cerqueira, Rute Maria ^a,d   Manso, M Conceição ^b,c   Correia, Manuel R ^a   Fernandes, Carolina D ^a   Vilar, Hélder ^a   Nora, Mário ^a   Martins, Paulo ^a  

^a Surgery S Sebastião Hospital   (Portugal)

^b UNIVERSIDADE FERNANDO PESSOA   (Portugal)

^c UNIVERSITY OF PORTO   (Portugal)

^d Hospital So Sebastio   (Portugal)

Author keywords

Bariatric surgery; Helicobacter pylori infection; Obesity

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; PROTON PUMP INHIBITOR;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; ERADICATION THERAPY; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; STOMACH BYPASS; TREATMENT DURATION; TREATMENT OUTCOME; UREA BREATH TEST;

ADULT; AMOXICILLIN; ANTI-BACTERIAL AGENTS; CLARITHROMYCIN; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; GASTRIC BYPASS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; OBESITY, MORBID; PROTON PUMP INHIBITORS; RETROSPECTIVE STUDIES;

EID: 80052355317     PISSN: 09608923     EISSN: 17080428     Source Type: Journal    
DOI: 10.1007/s11695-010-0254-4     Document Type: Article

References (28)

1. MA Maggard LR Shugarman M Suttorp 2005 Meta analysis: surgical treatment of obesity Ann Intern Med. 142 547 559 15809466
2. S Sauerland L Angrisani M Belachew, et al. 2005 Obesity surgery: evidence based guidelines of the European Association for Endoscopy Surgery (EAES) Sur Endosc. 19 200 221 10.1007/s00464-004-9194-1 1:STN:280:DC%2BD2M3js1Sltw%3D%3D (Pubitemid 40691215)
3. D Azagury JM Dumonceau P Morel, et al. 2006 Preoperative work-up in asymptomatic patients undergoing Roux-en-y gastric bypass: is endoscopy mandatory? Obes Surg. 16 1304 1311 17059738 10.1381/096089206778663896 1:STN:280:DC%2BD28nislansA%3D%3D (Pubitemid 44671801)
4. A Csendes AM Burgos G Smok, et al. 2007 Endoscopic and histologic findings of the foregut in 426 patients with morbid obesity Obes Surg. 17 28 34 17355765 10.1007/s11695-007-9002-9
5. A De Moura Almeida HP Cotrim AS Santos, et al. 2008 Preoperative upper gastrointestinal endoscopy in obese patients undergoing bariatric surgery: is it necessary? Surg Obes Relat Dis. 4 144 151 18294926 10.1016/j.soard.2007.12.006
6. R Muñoz L Ibañez J Salinas, et al. 2009 Importance of routine preoperative upper endoscopy: why all patients should be evaluated? Obes Surg. 19 427 431 18795381 10.1007/s11695-008-9673-x
7. Anonymous 1994 NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH consensus development panel on Helicobacter pylori in peptic ulcer disease JAMA. 272 65 69 10.1001/jama.272.1.65 (Pubitemid 24195449)
8. GD Eslick LL Lim GE Byles, et al. 1999 Association of Helicobacter pylori infection with gastric carcinoma: a meta analysis Am J Gastroenterol. 94 2372 2379 10.1111/j.1572-0241.1999.01360.x (Pubitemid 29420659)
9. S Suerbaum P Michetti 2002 Helicobacter pylori infection N Engl J Med. 347 1175 1186 12374879 10.1056/NEJMra020542 1:CAS:528:DC%2BD38XnslShsbo%3D
10. M Quina A Guerreiro 2001 Gastric cancer (carcinoma) and Helicobacter pylori: situation in Portugal Hepato-Gastroenterol. 48 1565 1568 1:STN:280:DC%2BD38%2Fos1aruw%3D%3D (Pubitemid 34003476)
11. J Ferlay P Autier M Boniol, et al. 2007 Estimates of cancer incidence and mortality in Europe in 2006 Ann Oncol. 18 581 592 17287242 10.1093/annonc/ mdl498 1:STN:280:DC%2BD2s7hslSgtw%3D%3D (Pubitemid 46359643)
12. A Ramaswamy E Lin BJ Ramshaw, et al. 2004 Early effects of Helicobacter pylori infection in patients undergoing bariatric surgery Arch Surg. 139 1094 1096 15492150 10.1001/archsurg.139.10.1094 (Pubitemid 39362276)
13. B Schirmer C Erenoglu A Miller 2002 Flexible endoscopy in the management of patients undergoing Roux-en-Y gastric bypass Obes Surg. 12 634 638 12448383 10.1381/096089202321019594 (Pubitemid 35305740)
14. JJ Rasmussen W Fuller MR Ali 2007 Marginal ulceration after laparoscopic gastric bypass. An analysis of predisposing factors in 260 patients Surg Endosc. 21 1090 1094 17514403 10.1007/s00464-007-9285-x 1:STN:280: DC%2BD2sznvFeqsg%3D%3D (Pubitemid 47024767)
15. AV Safatle Ribeiro R Kuga K Iriya, et al. 2007 What to expect in the excluded stomach mucosa after vertical banded Roux-en-y gastric bypass for morbid obesity J Gastrointest Surg. 11 133 137 17390161 10.1007/s11605-006-0047- 1
16. A Escalona S Guzman L Ibanez, et al. 2005 Gastric cancer after Roux-en-Y gastric bypass Obes Surg. 15 423 427 15826480 10.1381/0960892053576668 (Pubitemid 40463612)
17. JL Harper D Beech DS Tichansky, et al. 2007 Cancer in the bypassed stomach presenting early after gastric bypass Obes Surg. 17 1268 1271 18074505 10.1007/s11695-007-9216-x (Pubitemid 351321340)
18. P Malfertheiner F Megraud C O'Morain, et al. 2007 Current concepts in the management of Helicobacter pylori Infection. The Maastrich III Consensus Report Gut. 56 772 781 17170018 10.1136/gut.2006.101634 1:STN:280: DC%2BD2szkslaksw%3D%3D (Pubitemid 46854190)
19. R Bender 2001 Calculating confidence intervals for the number needed to treat Control Clin Trials. 22 102 110 11306148 10.1016/S0197-2456(00)00134-3 1:STN:280:DC%2BD3MzgslKmtA%3D%3D (Pubitemid 32289446)
20. T Lind S Veldhuyzen van Zaten P Unge, et al. 1996 Eradication of Helicobacter pylori using one week triple therapies combining omeprazole with two antimicrobials. The MACH I study Helicobacter. 1 138 144 9398894 10.1111/j.1523-5378.1996.tb00027.x 1:STN:280:DyaK1c%2FmtFWnsA%3D%3D (Pubitemid 126671139)
21. WD Chey BC Wong 2007 American College of Gastroenterology guideline on the management of Helicobacter pylori infection Am J Gastroenterol. 102 1808 1825 17608775 10.1111/j.1572-0241.2007.01393.x 1:CAS:528:DC%2BD2sXhtVemsLrI (Pubitemid 47206706)
22. DJ Kearney A Brousal, et al. 2000 Treatment of Helicobacter pylori Infection in clinical practice in the United States Dig Dis Sci. 45 265 271 10711436 10.1023/A:1005444006042 1:STN:280:DC%2BD3c7nsVGkug%3D%3D (Pubitemid 30133884)
23. RJ Saad WD Chey 2006 Treatment of Helicobater Pylori infection in 2006 Gastroenterol Hepatol Ann Rev. 1 30 35
24. A Kadayifci H Buyukhatipoglu M Cemil Savas, et al. 2006 Eradication of Helicobacter pylori with triple therapy: an epidemiological analysis of trends in Turkey over 10 Years Clin Ther. 28 1960 1966 17213016 10.1016/j.clinthera. 2006.11.011 1:CAS:528:DC%2BD2sXhtVCltLo%3D (Pubitemid 46043508)
25. X Calvet N Garcia T López, et al. 2000 A meta-analysis of short versus long therapy with a proton pump inhibitor, clarithromycin and either metronidazole or amoxycilin for treating Helicobacter pylori infection Aliment Pharmacol Ther. 14 603 609 10792124 10.1046/j.1365-2036.2000.00744.x 1:CAS:528:DC%2BD3cXjvFSgsLo%3D (Pubitemid 30240753)
26. L Fuccio ME Minardi RM Zagari, et al. 2007 Meta-analysis: duration of first line proton pump inhibitor based triple therapy for Helicobacter pylori eradication Ann Intern Med. 147 553 562 17938394 (Pubitemid 351664506)
27. F Mégraud 2004 H Pylori antibiotic resistance: prevalence, importance and advances in testing Gut. 53 1374 1384 15306603 10.1136/gut.2003.022111 (Pubitemid 39120130)
28. J Cabrita M Oleastro R Matos 2000 Features and trends in Helicobacter pylori antibiotic resistance in Lisbon area, Portugal (1990-1999) J Antimicrob Chemother. 46 1029 1031 11102427 10.1093/jac/46.6.1029 1:CAS:528:DC%2BD3MXotlOh (Pubitemid 32000618)